Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2

Página do item simplificado
dc.contributor.authorFilho, Marcos Antonio Bonacorso Manhanelli
dc.contributor.authorDuarte Júnior, Eliud Garcia
dc.contributor.authorMariuba, Jamil Victor de Oliveira
dc.contributor.authorLinardi, Fábio
dc.contributor.authorCosta, José Augusto
dc.contributor.authorGali Filho, Julio Cesar
dc.contributor.authorYoshida, Winston Bonetti [UNESP]
dc.contributor.authorFilho, Julio Cesar Gali
dc.contributor.institutionPontifícia Universidade Católica de São Paulo – PUC-SP
dc.contributor.institutionConjunto Hospitalar de Sorocaba
dc.contributor.institutionCirurgia Vascular e Endovascular
dc.contributor.institutionUniversidade Vila Velha – UVV
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionJJMED
dc.date.accessioned2021-06-25T11:09:19Z
dc.date.available2021-06-25T11:09:19Z
dc.date.issued2020-01-01
dc.description.abstractThe current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.en
dc.description.affiliationPontifícia Universidade Católica de São Paulo – PUC-SP
dc.description.affiliationConjunto Hospitalar de Sorocaba
dc.description.affiliationHospital Santa Mônica Cirurgia Vascular e Endovascular
dc.description.affiliationUniversidade Vila Velha – UVV
dc.description.affiliationUniversidade Estadual Paulista “Júlio de Mesquita Filho” – UNESP
dc.description.affiliationJJMED
dc.description.affiliationUnespUniversidade Estadual Paulista “Júlio de Mesquita Filho” – UNESP
dc.format.extent1-7
dc.identifierhttp://dx.doi.org/10.1590/1677-5449.200072
dc.identifier.citationJornal Vascular Brasileiro, v. 19, p. 1-7.
dc.identifier.doi10.1590/1677-5449.200072
dc.identifier.fileS1677-54492020000100623.pdf
dc.identifier.issn1677-7301
dc.identifier.issn1677-5449
dc.identifier.scieloS1677-54492020000100623
dc.identifier.scopus2-s2.0-85097958387
dc.identifier.urihttp://hdl.handle.net/11449/208264
dc.language.isoeng
dc.relation.ispartofJornal Vascular Brasileiro
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectArterial thrombosis
dc.subjectCOVID-19
dc.subjectHeparin
dc.subjectLimb ischemia
dc.subjectThromboembolism
dc.titleAlprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2en
dc.titleAlprostadil associado a heparina de baixo peso molecular para o tratamento da isquemia de membros causada por SARS-CoV2pt
dc.typeArtigo

Arquivos

Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
S1677-54492020000100623.pdf
Tamanho:
1.17 MB
Formato:
Adobe Portable Document Format
Baixar

Coleções

Artigos - Cirurgia e Ortopedia - FMB